Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive Leukemia.
Loff S, Dietrich J, Meyer JE, Riewaldt J, Spehr J, von Bonin M, Gründer C, Swayampakula M, Franke K, Feldmann A, Bachmann M, Ehninger G, Ehninger A, Cartellieri M.
Loff S, et al. Among authors: cartellieri m.
Mol Ther Oncolytics. 2020 Apr 29;17:408-420. doi: 10.1016/j.omto.2020.04.009. eCollection 2020 Jun 26.
Mol Ther Oncolytics. 2020.
PMID: 32462078
Free PMC article.